Dedicated and energetic, Julie J. Hong, Ph.D. instills nothing but confidence in her clients. From the young, start-up to the well-established pharmaceutical company, each of her clients knows its biotech innovations are safe under her watch. Her years of experience in prosecuting applications, both domestic and worldwide, give her that edge – Dr. Hong will provide the most careful and creative strategy for locking-in the best patent protection. Her advanced training in biochemistry and molecular biology has prepared her to tackle even the most complex biotechnologies.
- Prosecutes applications directed to compounds for treating metabolic diseases, including diabetes and obesity, in addition to therapeutics for renal disorders, cardiovascular disease, autoimmune disease, neurological disorders, and blood conditions – some of which are now in clinical trials.
- Manages complex portfolios relating to pharmaceutical quality control assays, stabilized pharmaceutical formulations, peptidomimetics, and stem cell therapy, and further provides her clients with IP landscape or freedom to operate analyses relating to blood factors, engineered antibodies, anti-cancer antibody-based compositions, insulin analogs, and HPV vaccines.
Dr. Hong’s experience encompasses a wide variety of biotechnology disciplines, including:
- Peptide-based therapeutics and diagnostics for diabetes
- Adoptive immunotherapy for the treatment of cancer,
- Gene-based diagnostics,
- Stem cell therapy
- Recombinant antibody production methods
- Coated medical devices
- High protein food products
- Plant transformation methods
Background and Credentials
In addition to prosecuting patent applications before the U.S. Patent and Trademark Office, Dr. Hong has extensive experience prosecuting foreign applications. Dr. Hong also has experience in preparing a variety of legal opinions, addressing issues such as patentability, inventorship, and the infringement, validity, and enforceability of patents. She also has participated in patent interference proceedings before the Board of Patent Appeals and Interferences.
Previously, Dr. Hong was a patent agent with another intellectual property firm based in Chicago. Prior to that experience, Dr. Hong worked as a graduate research assistant at Purdue University. In four years, she successfully completed her graduate studies and received a Ph.D. in biochemistry and molecular biology. She received her B.S. in chemistry with an emphasis in biochemistry from Loyola University Chicago in 1997.
- Purdue University (Ph.D.)
- Biochemistry and Molecular Biology
- Loyola University Chicago (B.S.)
- U.S. Patent and Trademark Office
Publications and Presentations
Dr. Hong’s representative scientific research publications include:
- Julie J. Hong, Regulation of Signaling in B Cells through the Phosphorylation of Syk on Linker Region Tyrosines, A Mechanism for Negative Signaling by the Lyn Tyrosine Kinase, Journal of Biological Chemistry, 277: 31703-31714 (2002).
- Julie J. Hong, The Engagement of Beta-1 Integrins on Promonocytic Cells Promotes Phosphorylation of Syk and Formation of a Protein Complex Containing Lyn and Beta-1 Integrin,European Journal of Immunology 29; 1426-1434 (1999).
Community and Professional Involvement
- Member, Women In Bio - San Francisco Bay Area Chapter